BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
search help
Documents 1-2 out of 2 found
  Current Search:  naglazyme: 188, galsulfase: 2  
59%
PDF
http://www.biomarinpharm.com/newsite/about-biomarin-history.sht
Su BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
This deal represented a major step in the company's evolution toward becoming a fully- integrated biopharmaceutical company.
BIOMARIN ANNOUNCES POSITIVE PHASE 3 DATA FROM CLINICAL TRIALS OF rhASB (GALSULFASE) FOR MPS VI.
Back to Top 2003 BIOMARIN RECEIVES...

author: sferris
Matching: galsulfase Find similar documents More document info

59%
PDF
http://www.biomarinpharm.com/newsite/about-biomarin-history.sht page 1


author: sferris
Matching: galsulfase Find similar documents More document info

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.